Cancer-related fatigue is one of the most frequent symptoms reported by patients, in all stages of the disease. Fatigue is related to secondary causes, such as anemia, electrolytes disorders, malnutrition or to cancer specific therapy chemotherapy, radiation or biologic treatment or is related to the disease itself.
Material and method.
Results and discussion. Most of them had low and moderate fatigue Many researches are focused on fatigue therapy - most of them studied the effect of stimulants, corticoids and cancer sarcoma symptoms interventions. The intensity of this symptom is reported differently by patient and by the physician, and this is a strong reason for assessing fatigue at every clinical evaluation cancer sarcoma symptoms the patients in palliative settings.
Tratamentul sarcoamelor Ce este sarcomul? Sarcomul este relativ rar la adulți, dar este unul dintre tipurile de cancer cele mai frecvente la copii; se răspândește adesea în alte țesuturi din organism.
The treatment option with very strong recommendation is based on non-pharmacological intervention. Oboseala în tumorile maligne solide este una dintre cele mai frecvente simptome raportate cancer sarcoma symptoms papillomavirus infection meaning în toate etapele bolii.
Oboseala este legată de cauze secundare, cum ar fi anemie, tulburări de electroliți, malnutriție sau la terapia specifică: chimioterapie, radioterapie sau biologice sau este legat de boala în sine. Material și metodă. Rezultate și discuții.
Multe cercetări sunt concentrate pe terapia oboselii - cele mai multe dintre ele au studiat diverse stimulente, corticoizi și intervenții non-farmacologice. Intensitatea acestui cancer abdominal sintomas este raportată în mod diferit de pacient și de medic, iar acest lucru este un motiv întemeiat pentru a măsura oboseala la fiecare evaluare clinică a pacienților în îngrijirile paliative.
Opțiunea de tratament se bazează pe intervenții non-farmacologice. Cancer-related fatigue is one of the most prevalent symptoms in cancer patients and it has been recognized by physicians, cancer sarcoma symptoms, caregivers, and researchers that fatigue needs clinical attention and strong intervention 3.
So, cancer-related fatigue has been accepted as a diagnosis in the International Classification of Diseases, Tenth Revision 3and clinical practice guidelines for its management have been formulated by the National Institutes of Health and the National Comprehensive Cancer Network NCCN 4,5. Fatigue may be regarded as a single symptom, as a symptom cluster or as a clinical syndrome 6. Fatigue is a subjective symptom and must be assessed at initial clinical evaluation of cancer patients, by self-evaluation and, only in isolated cases cognitive impairments can be substituted by estimations of caregivers or medical staff cancer sarcoma symptoms.
For the single-symptom approach, single item scales analog-visual scale have cancer sarcoma symptoms proposed. Initially, in the management of fatigue should be considered the cancer sarcoma symptoms causes of fatigue and these must be correctly treated.
So, the patient should be evaluated for anemia, depression, thyroid disorders, hypercalcaemia, cancer sarcoma symptoms imbalance, malnutrition, too. Most of the patients with cancer-related fatigue will benefit from the non-pharmacological treatment, such as exercises, cognitive behavioral cancer sarcoma symptoms, and sleep intervention. Symptomatological pharmacological treatment is based on stimulants, such as methylphenidate, modafinil, pemoline and donazepil, and corticoids 2,4,6.
In the final stage of life, fatigue may provide protection and shielding from suffering for the patient and treatment of fatigue may be detrimental 6.
The severity of fatigue at the time of assessment is rated from 0 to 10 on a numerical scale, with 0 meaning that the symptom is absent, meaning low intensity of fatigue, meaning moderate intensity of fatigue, and cancer sarcoma symptoms severe level of fatigue. The participants were explained the purpose and the importance of the study and the patients signed a written informed consent, in which they cancer sarcoma symptoms agreed to join the study.
Data obtained were analyzed using Microsoft Office Excell However, cancer site does not seem to influence significantly the degree of fatigue There were differences between the results of the study and the expectancy of the investigators, especially in prostate cancer patients, who seemed to have a very good performance status and a very good tolerance of the specific treatment.
It is known that the prevalence and the impact of fatigue often have not been recognized by physicians In the last years, the studies focused on fatigue treatment to increase the quality of life. Research on symptomatic treatment of fatigue, in palliative care, has been concentrated on stimulant drugs such as methylphenidate, modafinil, dexmethylphenidate, pemoline and donazepil.
Cancer sarcoma symptoms routine use of these drugs in palliative care patients was considered controversial in the expert group because the available evidences are being too poor 6.
The potentially useful interventions in cancer-related fatigue are: the correction of metabolic disorders, anemia, depression, insomnia, modifications in periods of activity and rest diarycognitive paraziti helicobacter pylori, behavioral therapy to modify sleep sleep hygiene and nutritional support In women with breast cancer receiving chemotherapy, exercise can significantly reduce the level of fatigue, and as the duration cancer sarcoma symptoms exercise increases, the intensity of fatigue declines In patients with melanoma receiving interferon-α, the combination of exercise and methylphenidate showed a positive effect on interferon-induced fatigue The management of fatigue in our patients included corticosteroids and light physical exercise cancer sarcoma symptoms.
Conclusions Fatigue is one of the most frequent symptom in cancer patients with advanced and metastatic disease and seems to be more pronounced in lung cancer in association, probably, with dyspnea.
The intensity of this symptom is reported differently by patient and by the physician and cancer sarcoma symptoms is a strong reason for assessing fatigue at every clinical evaluation of the patients in palliative settings. The treatment of the fatigue rest limited to non-pharmacological interventions and the results are inconsistent.
Limitation of the study: a multicenter study with a larger sample size would allow for more definite conclusions. Cancer-related fatigue.
Clinical Practice Guidelines in Oncology.
Tipuri de sarcom
J NatlComprCancNetw. Cancer-related fatigue: a review.
Revista da Associação Médica Brasileira, 57 2 Maarten H. M, Pascal J.
Patient Diagnosed with a Rare Sarcoma Tumor
Oncology Williston Park ;— Accessed April 27, Radbruch Cancer sarcoma symptoms, Strasser F. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory, Cancer ; — A multidimensional measure of fatigue for use with cancer cancer sarcoma symptoms. Cancer Pract ; 6: — The symptoms of advanced cancer: relationship to age, gender, and performance status in 1, patients.
Support Care Cancer ; —9.
Managementul oboselii în îngrijirile paliative
Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer ; — Escalante CP. Treatment of cancer-related fatigue: an update. Support Care Cancer ; 79— Iop A. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey.
The fatigue coalition. SeminHematol ; 4— Patient-related barriers to fatigue communication.
Sarcom – Tot ce trebuie să ştii despre acest tip de cancer
Initial validation of the fatigue management barriers questionnaire. J Pain Symptom Manage ; — Exercise reduces daily fatigue inwomen with breast cancer receiving chemotherapy. Med Sci Sports Exerc, ; — Interferon-induced fatigue inpatients with melanoma: a pilot study of exercise and methylphenidate, Oncol Nurs Forum ; E85—E